Assessing risks of Plasmodium falciparum resistance to select next-generation antimalarials.
Saved in:
| Title: | Assessing risks of Plasmodium falciparum resistance to select next-generation antimalarials. |
|---|---|
| Authors: | Duffey M; Medicines for Malaria Venture, Geneva, Switzerland., Blasco B; Medicines for Malaria Venture, Geneva, Switzerland; Global Antibiotic Research and Development Partnership, Geneva, Switzerland., Burrows JN; Medicines for Malaria Venture, Geneva, Switzerland., Wells TNC; Medicines for Malaria Venture, Geneva, Switzerland., Fidock DA; Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA., Leroy D; Medicines for Malaria Venture, Geneva, Switzerland. Electronic address: leroyd@mmv.org. |
| Source: | Trends in parasitology [Trends Parasitol] 2021 Aug; Vol. 37 (8), pp. 709-721. Date of Electronic Publication: 2021 May 14. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review |
| Journal Info: | Publisher: Elsevier Science Country of Publication: England NLM ID: 100966034 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1471-5007 (Electronic) Linking ISSN: 14714922 NLM ISO Abbreviation: Trends Parasitol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
